Akoya Biosciences, Inc. (AKYA)

4.0400 +0.0500 (+1.25%) 收市：04:00PM EDT

Akoya Biosciences, Inc.

100 Campus Drive
6th Floor
Marlborough, MA 01752
United States
855 896 8401
https://www.akoyabio.com

版塊: Healthcare
行業: Medical Instruments & Supplies
全職員工: 330

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Brian McKelligon	President, CEO & Director	854.99k	無	1969
Mr. John Frederick Ek	CFO, Principal Financial Officer & Principal Accounting Officer	496.76k	無	1976
Dr. Frederic G. Pla Ph.D.	Chief Operating Officer	581.23k	無	1959
Priyam Shah	Senior Director of Business Development & Investor Relations Strategy	無	無	無
Ms. Jennifer Kamocsay	General Counsel	無	無	1971
Dr. Niro Ramachandran Ph.D.	Chief Business Officer	298.18k	無	1975
Dr. Pascal Bamford Ph.D.	Senior Vice President, Research & Development and Laboratory Operations	無	無	無
Mr. Rob C. Hart CFA, J.D.	Secretary	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

公司管治

截至 2024年5月1日 止，Akoya Biosciences, Inc. 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中：4；董事會：7；股東權利：8；現金賠償：9。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。